Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |